Connection
Todd Pitts to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications Todd Pitts has written about Cyclin-Dependent Kinase Inhibitor p21.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.135 |
|
|
|
-
Pitts TM, Bradshaw-Pierce EL, Bagby SM, Hyatt SL, Selby HM, Spreafico A, Tentler JJ, McPhillips K, Klauck PJ, Capasso A, Diamond JR, Davis SL, Tan AC, Arcaroli JJ, Purkey A, Messersmith WA, Ecsedy JA, Eckhardt SG. Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer. Oncotarget. 2016 Aug 02; 7(31):50290-50301.
Score: 0.135